1Gaver RC, Deeb G, Piltman KA, eL al. Dispositinn of anagrelide, an inhibitor of platelet aggregation. Clin Pharmacol Ther, 1981, 29 : 381-386.
2Petrides PE, Gisslinger H, Sterner M, et al. Pharmacokinetics, bioequivalence, tolerabi|ily, and eftcts on platelet counts of two lbrmulations of anagrelide in healthy volunteers and patients with thrombocythemia associated with Ther,2009, 31: 386-398.
